MedPath

Endotracheal Suctionning During Positive Pressure Extubation in ICU

Not Applicable
Not yet recruiting
Conditions
Mechanical Ventilation With Oral Intubation
Weaning Invasive Mechanical Ventilation
Oxygen Saturation Measurement
Rox Index
Extubation
Registration Number
NCT07130123
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Brief Summary

The aim of this clinical trial is to evaluate endotracheal suctioning during positive pressure extubation in mechanically ventilated adult patients (over 18 years old) in the intensive care unit (ICU). The main question it aims to answer is whether the intervention improves the respiratory oxygenation index (ROX) three hours after extubation compared to no endotracheal suction during positive pressure extubation.

Participants will only need to be extubated by the nursing team in the ICU. Follow-up will consist of evaluating respiratory rate, pulse oximetry and inspired oxygen fraction for three hours following extubation.

Detailed Description

This is a prospective, randomised, controlled trial. The aim of this study is to evaluate endotracheal suctioning during positive pressure extubation in mechanically ventilated adult patients (over 18 years old) in the intensive care unit (ICU). The main question it aims to answer is whether the intervention improves the respiratory oxygenation index (ROX) three hours after extubation compared to no endotracheal suction during positive pressure extubation.

Inclusion : Participants who meet eligibility criteria will be randomized into experimental arm (endotracheal suctioning during positive pressure extubation) or control arm (no endotracheal suction during positive pressure extubation).

Intervention and Follow-up : participants will only need to be extubated by the nursing team in the ICU. Follow-up will consist of evaluating respiratory rate, pulse oximetry and inspired oxygen fraction for three hours following extubation.

End of study : at the end of the study visit (28 days after extubation), vital status of participants will be recorded.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Adult patient
  • Intubated for more than 48 hours
  • Patient for whom extubation is prescribed by the patient's physician
Exclusion Criteria
  • Headboard restriction>30°.
  • Decision to limit active treatment in advance of reintubation
  • Protected person (under guardianship or curatorship)
  • Person under court protection
  • Persons deprived of liberty
  • Persons not affiliated to a social security scheme
  • Pregnant or breast-feeding woman
  • No co-inclusion with a study whose period of interest is follow-up within 3 hours of extubation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Respiratoy/oxygenation index (ROX index)3 hours after extubation

Rox index will be assessed 3 hours after extubation by an investigator with no information about randomization (blind assessment)

Secondary Outcome Measures
NameTimeMethod
Mechanical ventilation weaning failureDuring 7 days after extubation

Weaning failure corresponds with death or new intabution

Airway clearance techniqueDuring 24 hours after extubation

Use of any airway clearance technique after extubation :

* nasotracheal suction

* respiratory physiotherapy

* bronchial fibroscopy

ROX index evolutionDuring 3 hours after extubation

Rox index will be assessed 3 times after extubation in order to evaluate its evolution (blind assessment) :

1. 30 minutes after extubation

2. 1 hour after extubation

3. 3 hour after extubation

Pneumonia after extubationDuring 7 days after extubation

Rate of hospital-acquired pneumonia confirmed by an investigator

Trial Locations

Locations (1)

Centre Hospitalier Universitaire d'Orléans

🇫🇷

Orléans, Loiret, France

Centre Hospitalier Universitaire d'Orléans
🇫🇷Orléans, Loiret, France
Cécile FOSSAT
Contact
+33238575252
cecile.fossat@chu-orleans.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.